Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523): contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Inge Tetens

Research output: Book/ReportReportResearchpeer-review

Abstract

EFSA-Q-2008-1291 , EFSA-Q-2008-1293 , EFSA-Q-2008-1303 , EFSA-Q-2008-1307 , EFSA-Q-2008-1309 , EFSA-Q-2008-1310 , EFSA-Q-2008-1314 , EFSA-Q-2008-1317 , EFSA-Q-2008-1325 , EFSA-Q-2008-1353 , EFSA-Q-2008-1490 , EFSA-Q-2008-1867 , EFSA-Q-2008-2054 , EFSA-Q-2008-2061 , EFSA-Q-2008-2062 , EFSA-Q-2008-3647 , EFSA-Q-2010-00642 , EFSA-Q-2010-00643
Original languageEnglish
PublisherEuropean Food Safety Authority
Publication statusPublished - 2010

Keywords

  • EPA
  • blood pressure
  • DPA
  • LDL-cholesterol
  • HDL-cholesterol
  • health claims
  • blood lipids
  • cardiovascular
  • triglycerides
  • DHA

Cite this